Get started
Author

Ambati Himaja

Selective HDAC3 Inhibitors with Potent In Vivo Antitumor Efficacy against Triple-Negative Breast Cancer
2023 · Sravani Pulya, Ambati Himaja, et al. · Journal of Medicinal Chemistry · 65
Fluorescent TICT Probe for Precise Monitoring of Cellular Lipid Droplets
2024 · Rikitha S Fernandes, Ambati Himaja, et al. · ACS Applied Bio Materials · 31
Synthesis, biological assessment, and in silico binding mode interaction analyses and DFT studies of biphenylsulfonamide-based potent MMP-2 inhibitors effective against chronic myeloid leukemia
2024 · Sandip Kumar Baidya, Tarun Patel, et al. · Journal of Molecular Structure · 24
Advances in the Delivery and Development of Epigenetic Therapeutics for the Treatment of Cancer
2023 · Aparajita Ghosh, Ambati Himaja, et al. · Molecular Pharmaceutics · 23
Exploration of benzimidazoles as potential microtubule modulators: An insight in the synthetic and therapeutic evolution
2021 · Kritika Laxmikeshav, Ambati Himaja, et al. · Journal of Molecular Structure · 23
Development of biotin decorated Olaparib loaded cationic lipopolymeric hybrid nanoparticle and evaluation of its anticancer effect and pharmacokinetics for triple negative breast cancer
2024 · Rajesh Pradhan, Shobha Kumari, et al. · Journal of Drug Delivery Science and Technology · 18
Biphenylsulfonamides as effective MMP‐2 inhibitors with promising antileukemic efficacy: Synthesis, in vitro biological evaluation, molecular docking, and MD simulation analysis
2024 · Sandip K. Baidya, Tarun Patel, et al. · Drug Development Research · 16
Derivatives of D(−) glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-I: Synthesis, biological screening and in silico binding interaction analysis
2024 · Sanjib Das, Subha Mondal, et al. · European Journal of Medicinal Chemistry · 15
Dual Stimuli-Responsive Gemcitabine-Conjugated Alginate-Chitosan Nanoparticles for Triple-Negative Breast Cancer Therapy: A Smart Approach
2025 · Tarun Patel, Ambati Himaja, et al. · Bioconjugate Chemistry · 13
Design and synthesis of pyridine-based benzamides as potent HDAC3 inhibitors as an armament against breast cancer with in vivo validation
2025 · Ambati Himaja, Ganesh Routholla, et al. · European Journal of Medicinal Chemistry · 13
Derivatives of D(−)-glutamine-based MMP-2 inhibitors as an effective remedy for the management of chronic myeloid leukemia-Part-III: Synthesis, biological screening and in silico binding interaction analysis
2024 · Sanjib Das, Tarun Patel, et al. · Bioorganic Chemistry · 10
PROTAC‐Based HDAC Degradation: A Paradigm Shift in Targeted Epigenetic Therapies
2025 · Ambati Himaja, Debojyoti Halder, et al. · ChemMedChem · 9
PDF
Engaging a highly fluorescent conjugated polymer network for probing endogenous hypochlorite in macrophage cells: improved sensitivity via signal amplification
2025 · Rikitha S. Fernandes, Neelam Gupta, et al. · Nanoscale Advances · 8
PDF
Synthesis and antiproliferative potency of 1,3,4-thiadiazole and 1,3-thiazolidine-4-one based new binary heterocyclic molecules: in vitro cell-based anticancer studies
2024 · Avik Maji, Ambati Himaja, et al. · RSC Medicinal Chemistry · 7
PDF
β-Carbolines linked γ-amino butyric acid/p-amino benzoic acid based carboxamides as histone deacetylase inhibitors: Design, synthesis, cytotoxicity and in silico studies
2025 · Akshay Kumawat, Himaja Ambati, et al. · International Journal of Biological Macromolecules · 3
BBB permeable selective HDAC3 inhibitor SP108 restores hippocampal plasticity and learning in a MAM-induced model of schizophrenia
2026 · Aparajita Ghosh, Himaja Ambati, et al. · Neuropharmacology · 1
Conjugated Nanoparticles for Biotechnology and Bio-Analysis
2024 · Aparajita Ghosh, Ambati Himaja, et al. · CRC Press eBooks · 1
Author response for "A new class of Indole-based HDAC8 inhibitors as potential anti-lung cancer agents: In silico design, synthesis, biological assessment and binding interaction analysis"
2026 · SAMIMA KHATUN, Venkatesh Muthukumar, et al. · Publons reviews and discussion
A new class of indole-based HDAC8 inhibitors as potential anti-lung cancer agents: in silico design, synthesis, biological assessment and binding interaction analysis
2026 · Samima Khatun, Venkatesh Muthukumar, et al. · RSC Medicinal Chemistry
One-pot synthesis of hexahydrobenzofuranyl-chromen-4-ones as tubulin polymerisation inhibitors: in vitro cytotoxicity evaluation and docking studies
2026 · Mary Sravani Galla, Akash Kumar Kharwar, et al. · New Journal of Chemistry
Nanotechnology for metabolic vascular diseases
2025 · Ambati Himaja, Aparajita Ghosh, et al. · Elsevier eBooks
Works count: 25
Citation count: 280
H-index: 10
I10-index: 11
Year
Topic
Type